EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease

Daisy Flatman, Richard W Naylor, Siobhan Crilly, Isabel Carter, Aleksandr Mironov, Emmanuel Pinteaux, Stuart M Allan, Rachel Lennon, Paul R Kasher

Matrix Biology · 2025-11 · 141 · 32-46

DOI: 10.1016/j.matbio.2025.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Matrix Biology, 2025-11. Verfasst von Daisy Flatman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Geoff…. Hauptthemen laut MEDLINE: Zebrafish, Collagen Type IV, Cerebral Small Vessel Diseases, Zebrafish Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Manchester, National Centre for the Replacement Refinement and Reduction of Animals in Research, Stroke Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral small vessel disease (cSVD) is a major cause of vascular dementia and stroke. Our understanding of cSVD pathophysiology is incomplete and our ability to treat patients is limited. Pathogenic variants in type IV collagen alpha 1 (COL4A1) cause a monogenic form of cSVD with variable age of onset, via disturbance of cerebrovascular basement membranes. Zebrafish larvae are a powerful model organism for studying cerebrovascular disease due to their optical clarity and applicability for live imaging. In this study, we characterised a zebrafish crispant model for loss-of-function COL4A1-associated cSVD that successfully recapitulates key disease features, including spontaneous intracerebral haemorrhage and cerebrovascular abnormalities. We also identified evidence for abnormal cerebrovascular basement membranes and elevated matrix metalloproteinase 9 (mmp9) transcription associated with loss of col4a1. Pharmacological inhibition of mmp9 was sufficient to ameliorate some cerebrovascular phenotypes. Finally, we describe the generation of a mutant line carrying a germline-transmissible 20 bp deletion in zebrafish col4a1 (col4a1Δ20) which is associated with cerebrovascular abnormalities, swimming defects and increased susceptibility to pharmacologically induced brain haemorrhages during larval stages. In adulthood, mutant col4a1Δ20 animals developed spontaneous brain haemorrhages that were observable in free-swimming fish. Overall, this study validates the use of zebrafish disease modelling for preclinical COL4A1-associated cSVD research and highlights its potential for further understanding disease pathophysiology and future drug discovery projects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishCollagen Type IVCerebral Small Vessel DiseasesZebrafish ProteinsAnimalsDisease Models, AnimalPhenotypeMatrix Metalloproteinase 9Basement MembraneCerebral HemorrhageHumans

Stichwörter der Autor:innen

Cerebral small vessel diseaseCerebrovasculatureCol4a1Intracerebral haemorrhageMMP9Type IV collagenZebrafish

Substanzen

Collagen Type IVMatrix Metalloproteinase 9Zebrafish Proteins

Autor:innen und Institutionen

  • Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Scienc…
  • Manchester Cell Matrix Centre, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of…
  • EM Core Facility (RRID: SCR_021147), Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Förderung

  • University of Manchester
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
  • Stroke Association
  • British Heart Foundation
  • Wellcome Trust
  • Kidney Research UK
  • UK Research and Innovation Medical Research Council
  • National Institute for Health and Care Research

Zitieren

APA

Flatman, D., Naylor, R. W., Crilly, S., Carter, I., Mironov, A., Pinteaux, E., Allan, S. M., Lennon, R., & Kasher, P. R. (2025). Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease. Matrix Biology, 141, 32-46. https://doi.org/10.1016/j.matbio.2025.08.005

Vancouver

Flatman D, Naylor RW, Crilly S, Carter I, Mironov A, Pinteaux E, et al. Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease. Matrix Biology. 2025;141:32-46. doi:10.1016/j.matbio.2025.08.005

BibTeX
@article{Flatman2025,
  author = {Flatman, Daisy and Naylor, Richard W and Crilly, Siobhan and Carter, Isabel and Mironov, Aleksandr and Pinteaux, Emmanuel and Allan, Stuart M and Lennon, Rachel and Kasher, Paul R},
  title = {Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease},
  journal = {Matrix Biology},
  year = {2025},
  volume = {141},
  pages = {32--46},
  doi = {10.1016/j.matbio.2025.08.005}
}
Kostenlos starten →